Correction for: ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling
Meng Zheng, Yuchun Niu, Junguo Bu, Shumei Liang, Zhilin Zhang, Jianhua Liu, Linlang Guo, Zhihua Zhang, Qiongyao Wang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Research Studies · RNA Research and Splicing · Signaling Pathways in Disease
This article has been corrected: The authors found that in Figure 4E, the histograms for CKMT1B molecule are identical in both the “Skipped Exon (SE)” and “Alternative 3’ss Exon (A3SS)” alternative splicing types. However, CKMT1B should only be associated with the A3SS alternative splicing event. The authors have replaced the duplicate CKMT1B histogram in the SE alternative splicing type with DNMT3B data from the original experiments. The authors point out that CKMT1B was not selected for further study as a downstream signaling molecule of ESRP1 and this duplication does not affect the article’s conclusions.
The corrected Figure 4 is presented below.